CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
administration) to reduce maintenance therapy without loss of asthma control in adolescent and adults with severe asthma..Study det...
Phase 3
Barcelona, Spain and 83 other locations
in patients ≥ 6 to \< 18 years of age with severe eosinophilic asthma, including a well-documented history of asthma exacerbations ...
Phase 3
Barcelona, Spain and 83 other locations
compared with placebo in participants with moderate-to-severe asthma.Study details include:* The study duration for each participant will be...
Phase 2
Barcelona, Spain and 24 other locations
is to investigate the safety, tolerability, and efficacy of dexpramipexole in participants with inadequately controlled severe eosinophilic asthma...
Phase 3
Barcelona, Spain and 102 other locations
12 years old with moderate to severe asthma....
Phase 2
Barcelona, Catalunya, Spain and 21 other locations
study to evaluate the effect of timely treatment with mepolizumab (NUCALA) to achieve clinical remission in adult participants with severe asthma...
Phase 4
Barcelona, Spain and 65 other locations
Primary Objective:* To evaluate the long-term safety and tolerability of dupilumab in pediatric patients with asthma who participated in a p...
Phase 3
Barcelona, Barcelona [Barcelona], Spain and 79 other locations
To assess the efficacy and safety of tezepelumab in pediatric participants with severe uncontrolled asthma on medium to high-dose inhaled co...
Phase 3
Barcelona, Spain and 120 other locations
to budesonide in children from 6 to less than 12 years of age with asthma.* The study duration will be up to 37 weeks including an investiga...
Phase 3
Barcelona, Catalunya, Spain and 51 other locations
The study is being conducted to evaluate the effect of 3 dosing regimens of povorcitinib on pulmonary function
Phase 2
Barcelona, Spain and 84 other locations
Clinical trials
Research sites
Resources
Legal